Apimeds Pharmaceuticals US, Inc. (AMEX:APUS) IPO

Apimeds Pharmaceuticals US, Inc.

IPO

Priced at US$4.00 a share on May 8, 2025.

Price
US$4.00 a share
Shares offered
3,375,000 shares of common stock
Offering size
US$13.5 million
Underwriters' option
Up to 506,250 more shares
Listing
APUS on NYSE American
Shares delivered
On or about May 12, 2025

Steps

StepWhen
Draft sent to the SEC in confidenceJan 29, 2024
Filed publiclySep 25, 2024
Amended 10 timesNewest May 2, 2025
Shares registered with an exchangeMar 3, 2025
Declared effective by the SECMay 5, 2025
Final prospectus, with the priceMay 9, 2025

Filings

FilingFiled
424B4 · ProspectusMay 9, 2025
EFFECT · Notice that a registration is effectiveMay 5, 2025
CORRESP · Letter to the SECMay 5, 2025
CORRESP · Letter to the SECMay 5, 2025
UPLOAD · Letter from the SECMay 5, 2025
POS AM · Amendment to an effective registrationMay 2, 2025
CORRESP · Letter to the SECMay 1, 2025
CORRESP · Letter to the SECMay 1, 2025
POS AM · Amendment to an effective registrationMay 1, 2025
UPLOAD · Letter from the SECMay 1, 2025
UPLOAD · Letter from the SECApr 30, 2025
POS AM · Amendment to an effective registrationApr 17, 2025
CERT · Exchange's certificate of listingMar 4, 2025
8-A12B · Registration of shares for listing on an exchangeMar 3, 2025
EFFECT · Notice that a registration is effectiveFeb 11, 2025
FWP · Free writing prospectusFeb 10, 2025
CORRESP · Letter to the SECFeb 10, 2025
S-1/A · Registration statement, amendedFeb 10, 2025
UPLOAD · Letter from the SECFeb 7, 2025
CORRESP · Letter to the SECFeb 7, 2025
CORRESP · Letter to the SECFeb 7, 2025
S-1/A · Registration statement, amendedFeb 6, 2025
S-1/A · Registration statement, amendedJan 29, 2025
S-1/A · Registration statement, amendedJan 10, 2025
S-1/A · Registration statement, amendedDec 20, 2024
CORRESP · Letter to the SECDec 19, 2024
UPLOAD · Letter from the SECDec 16, 2024
S-1/A · Registration statement, amendedDec 9, 2024
S-1/A · Registration statement, amendedNov 8, 2024
S-1 · Registration statementSep 25, 2024
DRS/A · Draft registration statement, amendedAug 5, 2024
DRSLTR · Letter to the SEC with a draftAug 2, 2024
DRS/A · Draft registration statement, amendedJun 17, 2024
DRSLTR · Letter to the SEC with a draftJun 14, 2024
UPLOAD · Letter from the SECMay 23, 2024
DRSLTR · Letter to the SEC with a draftMay 13, 2024
DRS/A · Draft registration statement, amendedMay 13, 2024
UPLOAD · Letter from the SECFeb 26, 2024
DRS · Draft registration statementJan 29, 2024

From the cover of the final prospectus (424B4) filed May 9, 2025